Trademark: 86944919
Status Date
Tuesday, October 30, 2018
Registration Number
5596122
Registration Date
Tuesday, October 30, 2018
Filing Date
Friday, March 18, 2016
Published for Opposition
Tuesday, August 9, 2016
5 Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy
Oct 30, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Oct 30, 2018
Registered-Principal Register
Sep 22, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 21, 2018
Allowed Principal Register - Sou Accepted
Sep 9, 2018
Statement Of Use Processing Complete
Aug 14, 2018
Use Amendment Filed
Sep 9, 2018
Case Assigned To Intent To Use Paralegal
Aug 14, 2018
Teas Statement Of Use Received
Mar 16, 2018
Notice Of Approval Of Extension Request E-Mailed
Mar 14, 2018
Sou Extension 3 Granted
Mar 14, 2018
Sou Extension 3 Filed
Mar 14, 2018
Sou Teas Extension Received
Sep 21, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 19, 2017
Sou Extension 2 Granted
Sep 19, 2017
Sou Extension 2 Filed
Sep 19, 2017
Sou Teas Extension Received
Mar 17, 2017
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2017
Sou Extension 1 Granted
Mar 15, 2017
Sou Extension 1 Filed
Mar 15, 2017
Sou Teas Extension Received
Oct 4, 2016
Noa E-Mailed - Sou Required From Applicant
Aug 9, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 9, 2016
Published For Opposition
Jul 20, 2016
Notification Of Notice Of Publication E-Mailed
Jul 6, 2016
Approved For Pub - Principal Register
Jun 29, 2016
Assigned To Examiner
Mar 23, 2016
New Application Office Supplied Data Entered
Mar 22, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
